All In MedTech

Device Trial Radar · NCT03261063

China Evera MRI® Study

Last checked: Nov 20, 2026Latest source record: Oct 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

15

Actual

Start

Oct 12, 2017

Primary completion

Sep 26, 2018

Study completion Sep 26, 2018

Sponsor

Sponsor type
Industry
First posted
Aug 24, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a prospective, single arm, non-blinded, multi-site study conducted in mainland China.

Conditions

  • Arrhythmias, Cardiac

Interventions

  • Evera MRI ICD SystemDevice

    Subjects are implanted with Evera MRI ICD System and exposed to MRI environment per study requirements

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of successful MRI scansTime frame: 1 Month Follow up visit after MRI Scan Visit

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Zhongshan Hospital

    Shanghai, Shanghai Municipality, China

  • Hua Xi Hospital (West China Hospital)

    Chengdu, Sichuan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.